173 related articles for article (PubMed ID: 11313796)
1. Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells.
Knipper R; Kuehlcke K; Schiedlmeier B; Hildinger M; Lindemann C; Schilz AJ; Fauser AA; Fruehauf S; Zeller WJ; Ostertag W; Eckert HG; Baum C
Gene Ther; 2001 Feb; 8(3):239-46. PubMed ID: 11313796
[TBL] [Abstract][Full Text] [Related]
2. MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions.
Schilz AJ; Schiedlmeier B; Kühlcke K; Fruehauf S; Lindemann C; Zeller WJ; Grez M; Fauser AA; Baum C; Eckert HG
Mol Ther; 2000 Dec; 2(6):609-18. PubMed ID: 11124062
[TBL] [Abstract][Full Text] [Related]
3. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
4. Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer.
Cmejlova J; Hildinger M; Cmejla R; Fuchs O; Kalabova D; Baum C; Jelinek J
Gene Ther; 2003 Jun; 10(12):1061-5. PubMed ID: 12776165
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
[TBL] [Abstract][Full Text] [Related]
6. Transduction of NIH 3T3 cells with a retrovirus carrying both human MDR1 and glutathione S-transferase pi produces broad-range multidrug resistance.
Doroshow JH; Metz MZ; Matsumoto L; Winters KA; Sakai M; Muramatsu M; Kane SE
Cancer Res; 1995 Sep; 55(18):4073-8. PubMed ID: 7664283
[TBL] [Abstract][Full Text] [Related]
7. Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivo.
Buss EC; Laufs S; Naundorf S; Kuehlcke K; Nagy KZ; Zeller WJ; Fruehauf S
Cytotherapy; 2006; 8(6):562-9. PubMed ID: 17148033
[TBL] [Abstract][Full Text] [Related]
8. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
Guo C; Jin X
Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
[TBL] [Abstract][Full Text] [Related]
9. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123.
Fruehauf S; Breems DA; Knaän-Shanzer S; Brouwer KB; Haas R; Löwenberg B; Nooter K; Ploemacher RE; Valerio D; Boesen JJ
Hum Gene Ther; 1996 Jun; 7(10):1219-31. PubMed ID: 8793546
[TBL] [Abstract][Full Text] [Related]
10. Transfer of the MDR1 (multidrug resistance) gene: protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo.
Licht T; Gottesman MM; Pastan I
Cytokines Mol Ther; 1995 Mar; 1(1):11-20. PubMed ID: 9384659
[TBL] [Abstract][Full Text] [Related]
11. Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice.
Licht T; Goldenberg SK; Vieira WD; Gottesman MM; Pastan I
Gene Ther; 2000 Feb; 7(4):348-58. PubMed ID: 10694816
[TBL] [Abstract][Full Text] [Related]
12. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
Suzuki M; Sugimoto Y; Tsukahara S; Okochi E; Gottesman MM; Tsuruo T
Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
[TBL] [Abstract][Full Text] [Related]
13. A bicistronic retroviral vector to introduce drug resistance genes into human umbilical cord blood CD34+ cells to improve combination chemotherapy tolerance.
Wang J; Chen Z; Xia X; Lu D; Xue J; Ruan C
Chin Med J (Engl); 2001 Jan; 114(1):25-9. PubMed ID: 11779430
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N',N"-triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo.
Kobune M; Xu Y; Baum C; Kelley MR; Williams DA
Cancer Res; 2001 Jul; 61(13):5116-25. PubMed ID: 11431349
[TBL] [Abstract][Full Text] [Related]
15. Retroviral-mediated transfer and functional expression of multidrug resistance gene in human placenta mesenchymal stem cells.
Han LY; Ye MZ; Li YP; Wang BW; Wang Q; Zhao SH; Li HL
Chin Med J (Engl); 2008 May; 121(9):800-5. PubMed ID: 18701045
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.
Takahashi S; Aiba K; Ito Y; Hatake K; Nakane M; Kobayashi T; Minowa S; Shibata H; Mitsuhashi J; Tsukahara S; Ishikawa E; Suzuki R; Tsuruo T; Sugimoto Y
Cancer Sci; 2007 Oct; 98(10):1609-16. PubMed ID: 17683514
[TBL] [Abstract][Full Text] [Related]
17. Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity.
Aksentijevich I; Cardarelli CO; Pastan I; Gottesman MM
Clin Cancer Res; 1996 Jun; 2(6):973-80. PubMed ID: 9816258
[TBL] [Abstract][Full Text] [Related]
18. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model.
Hanania EG; Deisseroth AB
Cancer Gene Ther; 1994 Mar; 1(1):21-5. PubMed ID: 7621234
[TBL] [Abstract][Full Text] [Related]
19. Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.
Hildinger M; Schilz A; Eckert HG; Bohn W; Fehse B; Zander A; Ostertag W; Baum C
Gene Ther; 1999 Jul; 6(7):1222-30. PubMed ID: 10455430
[TBL] [Abstract][Full Text] [Related]
20. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]